Primary Site >> Colorectal Cancer
Gene >> BMX
| 1. | |||||||||||
| Journal: | PLoS One. 2013 Nov 27;8(11):e81592. | ||||||||||
| Title: | Anti-cancer activity of an osthole derivative, NBM-T-BMX-OS01: targeting vascular endothelial growth factor receptor signaling and angiogenesis. | ||||||||||
| Author: | Yang, Hung-Yu|Hsu, Ya-Fen|Chiu, Pei-Ting|Ho, Shiau-Jing|Wang, Chi-Han|Chi, Chih-Chin|Huang, Yu-Han|Lee, Cheng-Feng|Li, Ying-Shiuan|Ou, George|Hsu, Ming-Jen | ||||||||||
| PMID: | 24312323 | ||||||||||
| 2. | |||||||||||
| Journal: | Neoplasia. 2014 Feb;16(2):147-57. | ||||||||||
| Title: | BMX acts downstream of PI3K to promote colorectal cancer cell survival and pathway inhibition sensitizes to the BH3 mimetic ABT-737. | ||||||||||
| Author: | Potter, Danielle S|Kelly, Paul|Denneny, Olive|Juvin, Veronique|Stephens, Len R|Dive, Caroline|Morrow, Christopher J | ||||||||||
| PMID: | 24709422 | ||||||||||
| 3. | |||||||||||
| Journal: | Cancer Res. 2015 Apr 1;75(7):1345-55. | ||||||||||
| Title: | BMX Negatively Regulates BAK Function, Thereby Increasing Apoptotic Resistance to Chemotherapeutic Drugs. | ||||||||||
| Author: | Fox, Joanna L|Storey, Alan | ||||||||||
| PMID: | 25649765 | ||||||||||
| 4. | |||||||||||
| Journal: | Cancer Res Treat. 2016 Jan;48(1):355-64. | ||||||||||
| Title: | Antitumor Activity of HM781-36B, alone or in Combination with Chemotherapeutic Agents, in Colorectal Cancer Cells. | ||||||||||
| Author: | Kang, Mi Hyun|Moon, Sung Ung|Sung, Ji Hea|Kim, Jin Won|Lee, Keun Wook|Lee, Hye Seung|Lee, Jong Seok|Kim, Jee Hyun | ||||||||||
| PMID: | 25761479 | ||||||||||
| 5. | |||||||||||
| Journal: | Mol Cancer Ther. 2016 Jun;15(6):1248-60. | ||||||||||
| Title: | Inhibition of PI3K/BMX Cell Survival Pathway Sensitizes to BH3 Mimetics in SCLC. | ||||||||||
| Author: | Potter, Danielle S|Galvin, Melanie|Brown, Stewart|Lallo, Alice|Hodgkinson, Cassandra L|Blackhall, Fiona|Morrow, Christopher J|Dive, Caroline | ||||||||||
| PMID: | 27197306 | ||||||||||